| (210) | Number of the EPO application | 17725086 |
| (220) | Filing date of the EPO application | 2017.05.11 |
| (80) | EPO patent specification publication (B) | EPB nr. 50/2023, 2023.12.13 |
| (110) | EPO patent number | 3463469 |
| (21) | Number of the application | e 2019 0390 |
| (71) | Name(s) of applicant(s), code of the country | Gilead Sciences, Inc., US; |
| (72) | Name(s) of inventor(s), code of the country | GAGGAR Anuj, US;
SUBRAMANIAN G. Mani, US; |
| (73) | Name(s) of owner(s), code of the country | GILEAD Sciences Inc., US; |
| (54) | Title of the invention | COMBINATION OF LEDIPASVIR AND SOFOSBUVIR FOR USE IN THE TREATMENT OF HEPATITIS B VIRUS INFECTIONS IN HUMANS |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | A61K 45/06 (2006.01.01); A61K 31/454 (2006.01.01); A61K 31/498 (2006.01.01); A61K 31/675 (2006.01.01); A61K 31/7072 (2006.01.01); A61P 31/14 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2019.05.31 |
| (30) | Priority | 201662342787 P, 2016.05.27, US |
| (86) | International application | PCT/US2017/032282, 2017.05.11 |
| (87) | International publication | WO 2017/205078, 2017.11.30 |